Kronik Obstrüktif Akciğer Hastalığı Değerlendirme Testinin diğer sağlıklı yaşam kalitesi değerlendirme testleri ile ilişkisi

Öz

Amaç: Stabil KOAH'ta Kronik Obstrüktif Akciğer Hastalığı (KOAH)'nın sağlık ve yaşam üzerindeki etkisini Kronik Obstrüktif Akciğer Hastalığı Değerlendirme Testi (CAT) ile değerlendirmek ve CAT'ın pratik kullanımını ölçmek. Yöntemler: Bu, son bir ayda alevlenme veya solunum fonksiyon testinde (SFT) reversibilite olmayan, ≥ 40 yaş stabil KOAH'lı hastaların katıldığı tek merkezli, kesitsel bir çalışmadır. Hastaların sağlık durumu ve solunum fonksiyonlarını değerlendirmek için CAT, SGRQ, BODE indeksi, PFT, altı dakikalık yürüme testleri (6 MWT) yaptık. CAT'ın solunum fonksiyon testleri, SGRQ skoru ve BODE indeksi ile korelasyonlarını analiz ettik ve CAT'nin iç tutarlılığını değerlendirdik ve CAT ve SGRQ için harcanan zamanı karşılaştırdık. Bulgular: Çalışmaya toplam 100 stabil KOAH hastası alındı, 87 hasta erkek ve ortalama yaş 63,68±7,73 idi. Ortalama CAT puanı 12.05±8.29 olup, test ve tekrar test CAT puanı arasında istatistiksel olarak anlamlı fark yoktu (p>0.05). Ortalama SGRQ skoru 37.75 ve ortalama BODE indeksi 3.2 idi ve CAT, hem SGRQ hem de BODE indeksi ile pozitif ve bir saniyedeki zorlu ekspiratuar hacim (FEV1) ile negatif korelasyon gösterdi. CAT, SGRQ'ya göre anlamlı olarak daha az zaman aldı (sırasıyla, 4,41±0,39 ve 8,21±0,75 dakika, p<0,05). Sonuç: CAT, stabil KOAH hastasının sağlıklı yaşam kalitesi ve fonksiyonel durumu hakkında SGRQ ve BODE indeksine benzer bilgi sağlayabilir ve daha az zaman harcar, bu nedenle daha pratik görünmektedir.

Anahtar Kelimeler

• Yaşam Kalitesi
• KOAH
• CAT
• SGRQ
• BODE İndeksi

The correlation of Chronic Obstructive Pulmonary Disease Assessment Test with other healthy life quality assessment tests

Abstract

Objective: To evaluate the effect of Chronic Obstructive Pulmonary Disease (COPD) on health and life with the Chronic Obstructive Pulmonary Disease Assessment Test (CAT) in stable COPD and to measure CAT's practical use. Methods: This is a single-center cross-sectional study of which participants were ≥ 40 years old patients with stable COPD and without any exacerbation in the last one month or reversibility in pulmonary function test (PFT). To evaluate the patients' health status and respiratory functions, we performed CAT, SGRQ, BODE index, PFT, six-minute walking tests (6 MWT). We analyzed the correlations of CAT with the pulmonary function tests, SGRQ score, and BODE index and assessed the internal consistency of CAT, and compared the time consumed for CAT and SGRQ. Results: A total of 100 stable COPD patients were enrolled in the study, 87 patients were male and the mean age was 63,68±7,73. The mean CAT score was 12.05±8.29, and there was no statistically significant difference between the test and re-test CAT score (p>0.05). The mean SGRQ score was 37.75 and the mean BODE index was 3.2 and CAT correlated positively with both SGRQ and BODE index and negatively with forced expiratory volume in one second (FEV1). CAT was significantly less time-consuming compared to SGRQ (respectively, 4,41±0,39 and 8,21±0,75 minutes, p<0,05). Conclusions: CAT can provide information about the stable COPD patient's healthy life quality and functional status similar to SGRQ and BODE index and consumes less time, thus seems more practical.

Keywords

• Quality of life
• COPD
• CAT
• SGRQ
• BODE Index

Kaynakça

1. 1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. 2020. www.goldcopd.org.
2. 2. Jones PW, Shahrour N, Nejjari C, Lahlou A, Doble A, Rashid N, et al. Psychometric evaluation of the COPD assessment test: data from the BREATHE study in the Middle East and North Africa region. Respir Med. 2012 Dec;106 Suppl 2:S86-99. doi: 10.1016/S0954-6111(12)70017-3.
3. 3. Akdemir SE, Özgür ES, Günakan G. Reliability and validity of Turkish version of COPD assessment test. Tuberk Toraks. 2012;60(4):314-20. doi: 10.5578/tt.4321.
4. 4. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report; 2009.
5. 5. Costa D, Jamami M. Bases fundamentais da espirometria. Braz J Phys Ther. 2001;5(2):95-102.
6. 6. Tsiligianni IG, Alma HJ, de Jong C, Jelusic D, Wittman M, Schuler M, et al. Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George’s Respiratory Questionnaire cutoff 25 (and 20) as reference. Int J Chron Obstruct Pulmon Dis 2016; 11: 1045–1052. DOI: 10.2147/COPD.S99793.
7. 7. Loubert A, Regnault A, Meunier J, Gutzwiller FS, Regnier SA. Is the St. George's Respiratory Questionnaire an Appropriate Measure of Symptom Severity and Activity Limitations for Clinical Trials in COPD? Analysis of Pooled Data from Five Randomized Clinical Trials. Int J Chron Obstruct Pulmon Dis. 2020; 15:2103-2113. doi: 10.2147/COPD.S261919. PMID: 32982203; PMCID: PMC7490086.
8. 8. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther. 2000; 9:1121-45. doi: 10.1016/S0149-2918(00)80089-2. PMID: 11048909.

9. 9. Rehman AU, Hassali MAA, Harun SN, Abbas S, Muneswarao J, Ali IABH et al. Validation and clinical interpretation of the St George's respiratory questionnaire for COPD (SGRQ-C) after adaptation to Malaysian language and culture, in patients with COPD. Health Qual Life Outcomes. 2020 May 13;18(1):138. doi: 10.1186/s12955-020-01393-1. PMID: 32404113; PMCID: PMC7218514.
10. 10. Flores MP, Arcuri JF, Carvalho da Silva MM, Pires Di Lorenzo VA. Validity of the Brazilian version of the COPD assessment test in patients with chronic obstructive pulmonary disease. Clin Respir J. 2020; 00:1–7. doi: 10.1111/crj.13308.
11. 11. Li CL, Lin MH, Chen PS, Tsai YC, Shen LS, Kuo HC, Liu SF. Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020; 15:389-395. doi: 10.2147/COPD.S234363. PMID: 32110007; PMCID: PMC7036670.
12. 12. Ong KC, Lu SJ, Soh CS. Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Int J Chron Obstruct Pulmon Dis. 2006;1(1):91-6. doi: 10.2147/copd.2006.1.1.91. PMID: 18046907; PMCID: PMC2706601.
13. 13. Singh S, Daga MK, Hira HS, Kumar L, Mawari G. Correlation of chronic obstructive pulmonary disease assessment test and clinical chronic obstructive pulmonary disease questionnaire score with BODE index in patients of stable chronic obstructive pulmonary disease. Lung India 2018; 35:494-8. PMID: 30381559
14. 14. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005 Mar 15;171(6):591-7. doi: 10.1164/rccm.200407-867OC. PMID: 15591470.
15. 15. Ghobadi H, Ahari S. S, Kameli A, M.Lari S. The Relationship between COPD Assessment Test (CAT)Scores and Severity of Airflow Obstruction in Stable COPD Patients. Tanaffos 2012; 11(2): 22-26. PMID: 25191410.
16. 16. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509. PMID: 19720809.